E. Kendall Pye, Ph.D., former President and CEO of Repap Technologies Inc and Vice-President, Science and Technology, Repap Enterprises Inc. In 1981, Dr. Pye was recruited by General Electric Venture Capital as President and CEO of the start-up biotechnology venture, Biological Energy Corporation. This company developed a precursor technology to the Alcell process and was then acquired by Repap Enterprises. Apart from his management and corporate duties, Dr. Pye led the research and marketing programs on bioactive compounds and biomaterials recovered from the $60 million Alcell demonstration plant.
As a faculty member in Biochemistry & Biophysics at the University of Pennsylvania School of Medicine from 1965-81, his research interests included biological oscillations, microbial metabolism and its control, fermentation, immobilized enzyme technology and enzyme kinetics. Over his professional career in biochemistry, biophysics and biotechnology, Dr. Pye has authored over 140 publications, received several patents, and edited several conference proceedings. He represented the United States as a delegate in scientific exchange missions to Japan, NATO, and the Soviet Union. He has served on industry and technical association boards and is a member of several professional societies.
Dr. Pye received his B.Sc. and Ph.D. in biochemistry from the University of Manchester, Institute for Science and Technology and completed a Post-Doctoral Fellowship with Dr. Britton Chance at the University of Pennsylvania in biophysics, studying metabolic control.
